Oligodendrocyte myelin glycoprotein growth inhibition function requires its conserved leucine-rich repeat domain, not its glycosylphosphatidyl-inositol anchor
- 28 April 2003
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 85 (4) , 889-897
- https://doi.org/10.1046/j.1471-4159.2003.01764.x
Abstract
The oligodendrocyte myelin glycoprotein (OMgp) inhibits neurite outgrowth and axonal regeneration after brain injury, but its normal function remains unknown. Several observations suggest its implication in cell growth regulation. Here we report an analysis of the domain requirement in OMgp proliferation inhibitory function. We first studied the OMgp protein sequence in 14 mammal species and observed a high conservation of its leucine-rich repeat (LRR) domain. The deletion of this LRR domain is responsible for a total loss of function in an in vitro expression system. The possible three-dimensional structure of the LRR domain of OMgp was modelled using the structure of Yersinia pestis YopM cytotoxin as a template. The predicted arrangement of the LRR segments is compatible with a function of OMgp as a binding protein. The OMgp is a glycosylphosphatidyl-inositol-linked protein anchored in the plasma membrane of oligodendrocytes and neurones. Using deletion mutagenesis, we demonstrated the dispensability of the glycosylphosphatidyl-inositol anchor for OMgp proliferation inhibition function. Our results suggest that OMgp is part of a receptor complex, either as a coreceptor or as a membrane-bound or soluble ligand, involved in the transmission of a growth suppressive signal.Keywords
This publication has 41 references indexed in Scilit:
- Nogo-66 receptor antagonist peptide promotes axonal regenerationNature, 2002
- Unusual molecular architecture of the Yersinia pestis cytotoxin YopM: a leucine-rich repeat protein with the shortest repeating unitJournal of Molecular Biology, 2001
- Structural diversity of leucine-rich repeat proteins 1 1Edited by F. CohenJournal of Molecular Biology, 1998
- Ras signaling and NF1Current Opinion in Genetics & Development, 1995
- Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growthNeuron, 1994
- A novel role for myelin-associated glycoprotein as an inhibitor of axonal regenerationNeuron, 1994
- Molecular basis of neurofibromatosis type 1 (NF1): Mutation analysis and polymorphisms in the NF1 geneHuman Mutation, 1994
- Toxicity determined in vitro by morphological alterations and neutral red absorptionToxicology Letters, 1985
- Patterns of Amino Acids near Signal‐Sequence Cleavage SitesEuropean Journal of Biochemistry, 1983
- Von Recklinghausen NeurofibromatosisNew England Journal of Medicine, 1981